Viewing Study NCT00686218


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-01-28 @ 7:27 PM
Study NCT ID: NCT00686218
Status: COMPLETED
Last Update Posted: 2014-08-15
First Post: 2008-05-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic phase chronic myelogenous leukemia View